Brief: Cipher Pharma Acquires Profitable Growth Dermatology Products From ParaPRO For $89.5 Mln
29/07/2024 12:12
July 29 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS ACQUIRES PROFITABLE GROWTH
DERMATOLOGY
PRODUCTS FROM PARAPRO FOR US$89.5 MILLION
* CIPHER PHARMACEUTICALS INC - ACQUIRES U.S. NATROBA
OPERATIONS
FOR $89.5 MILLION
Source text for Eikon: ID:nCNWlbSRxa
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million